Year All20242023202220212020201920182017201620152014 Sep 19, 2018 Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Sep 17, 2018 Soleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric Endocrinology Sep 06, 2018 Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients Sep 04, 2018 Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi Syndrome Aug 14, 2018 Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results Jul 30, 2018 Soleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi Syndrome Jun 04, 2018 Soleno Therapeutics To Present Corporate Update at the BIO International Convention May 16, 2018 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results May 14, 2018 Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome Apr 02, 2018 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
Sep 19, 2018 Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease
Sep 17, 2018 Soleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric Endocrinology
Sep 06, 2018 Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients
Sep 04, 2018 Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi Syndrome
Aug 14, 2018 Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
Jul 30, 2018 Soleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi Syndrome
May 16, 2018 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 14, 2018 Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
Apr 02, 2018 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results